Pharmacological inhibition of MYC to mitigate chemoresistance in preclinical models of squamous cell carcinoma
Theranostics · 2024
DOI: 10.7150/thno.88759 ↗Kurz gefasst
Fachartikel in der Zeitschrift Theranostics, 2024. Verfasst von Shuo Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology, Beijing 100081, China. National Center of Stomato…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Head and Neck Neoplasms, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 19-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology, Beijing 100081, China. National Center of Stomatology & National Clinical Research Center for Oral Diseases & National…
Zitieren
APA
Liu, S., Qin, Z., Mao, Y., Wang, N., Zhang, W., Wang, Y., Chen, Y., Jia, L., & Peng, X. (2024). Pharmacological inhibition of MYC to mitigate chemoresistance in preclinical models of squamous cell carcinoma. Theranostics. https://doi.org/10.7150/thno.88759
Vancouver
Liu S, Qin Z, Mao Y, Wang N, Zhang W, Wang Y, et al. Pharmacological inhibition of MYC to mitigate chemoresistance in preclinical models of squamous cell carcinoma. Theranostics. 2024. doi:10.7150/thno.88759
BibTeX
@article{Liu2024,
author = {Liu, Shuo and Qin, Zhen and Mao, Yaqing and Wang, Ning and Zhang, Wenbo and Wang, Yujia and Chen, Yiwen and Jia, Lingfei and Peng, Xin},
title = {Pharmacological inhibition of MYC to mitigate chemoresistance in preclinical models of squamous cell carcinoma},
journal = {Theranostics},
year = {2024},
doi = {10.7150/thno.88759}
}
EUVIMED